메뉴 건너뛰기




Volumn 112, Issue 3, 2013, Pages 209-216

Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries

Author keywords

Europe; Financial recession; Medicines price comparison; On patent medicines

Indexed keywords

ALEMTUZUMAB; CETUXIMAB; DRUG; EMTRICITABINE; EXENDIN 4; LOPINAVIR PLUS RITONAVIR; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RAPAMYCIN; SITAGLIPTIN; TACROLIMUS;

EID: 84887036471     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2013.08.012     Document Type: Article
Times cited : (29)

References (40)
  • 1
    • 84887068801 scopus 로고    scopus 로고
    • Pharmaceutical expenditure. As percentage of total expenditure on health
    • OECD
    • OECD Pharmaceutical expenditure. As percentage of total expenditure on health. Health: Key Tables from OECD 2013, 10.1787/pharmexp-table-2013-1-en.
    • (2013) Health: Key Tables from OECD
  • 2
    • 79959752316 scopus 로고    scopus 로고
    • Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
    • Vogler S., Habl C., Bogut M., Voncina L. Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States. Croatian Medical Journal 2011, 52:183-197.
    • (2011) Croatian Medical Journal , vol.52 , pp. 183-197
    • Vogler, S.1    Habl, C.2    Bogut, M.3    Voncina, L.4
  • 6
    • 84887055363 scopus 로고    scopus 로고
    • WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
    • Glossary of Pharmaceutical Terms 2011, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. http://whocc.goeg.at/Glossary/Search.
    • (2011) Glossary of Pharmaceutical Terms
  • 7
    • 83555163611 scopus 로고    scopus 로고
    • External price referencing in Europe - a descriptive overview of one policy with many national characteristics
    • Leopold C., Vogler S., et al. External price referencing in Europe - a descriptive overview of one policy with many national characteristics. Health Policy 2012, 104(1):50-60. 10.1016/j.healthpol.2011.09.008.
    • (2012) Health Policy , vol.104 , Issue.1 , pp. 50-60
    • Leopold, C.1    Vogler, S.2
  • 8
    • 84924572521 scopus 로고    scopus 로고
    • Short- and long-term effects of value-based pricing versus external price referencing
    • Kanavos P., Nicod E., Espin J., van den Aardweg S. Short- and long-term effects of value-based pricing versus external price referencing. EMINet 2010, http://whocc.goeg.at/Literaturliste/Dokumente/FurtherReading/Short-%20and%20long-term%20effect%20of%20value-based%20pricing.pdf.
    • (2010) EMINet
    • Kanavos, P.1    Nicod, E.2    Espin, J.3    van den Aardweg, S.4
  • 10
    • 84864376612 scopus 로고    scopus 로고
    • Discounts and rebates granted to public payers for medicines in European countries
    • Vogler S., Zimmerman N., Piessnegger J., Bucsics A. Discounts and rebates granted to public payers for medicines in European countries. Southern Med Review 2012, 5(1):38-46.
    • (2012) Southern Med Review , vol.5 , Issue.1 , pp. 38-46
    • Vogler, S.1    Zimmerman, N.2    Piessnegger, J.3    Bucsics, A.4
  • 11
    • 84887058979 scopus 로고    scopus 로고
    • Internationale Arzneimittelpreisvergleiche: meta-analyse
    • Rosian I., Vogler S., Stürzlinger H. Internationale Arzneimittelpreisvergleiche: meta-analyse. Pharmig 2004, http://whocc.goeg.at/Publications/BooksReports.
    • (2004) Pharmig
    • Rosian, I.1    Vogler, S.2    Stürzlinger, H.3
  • 12
    • 2142825070 scopus 로고    scopus 로고
    • International differences in drug prices
    • Wagner J.L., McCarthy E. International differences in drug prices. Annual Review Public Health 2004, 25:475-495. 10.1146/annurev.publhealth.25.101802.123042.
    • (2004) Annual Review Public Health , vol.25 , pp. 475-495
    • Wagner, J.L.1    McCarthy, E.2
  • 13
    • 0034070190 scopus 로고    scopus 로고
    • Cross national price differences for pharmaceuticals: how large and why
    • Danzon P.M., Chao L.W. Cross national price differences for pharmaceuticals: how large and why. Journal of Health Economics 2000, 19:159-195.
    • (2000) Journal of Health Economics , vol.19 , pp. 159-195
    • Danzon, P.M.1    Chao, L.W.2
  • 15
    • 36348988465 scopus 로고    scopus 로고
    • International comparison of generic medicine prices
    • Simoens S. International comparison of generic medicine prices. Current Medical Research and Opinion 2007, 23(11):2647-2654.
    • (2007) Current Medical Research and Opinion , vol.23 , Issue.11 , pp. 2647-2654
    • Simoens, S.1
  • 16
    • 58149522302 scopus 로고    scopus 로고
    • Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
    • Cameron A., Ewen M., Ross-Degnan D., Ball D., Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. The Lancet 2009, 373(9659):240-249.
    • (2009) The Lancet , vol.373 , Issue.9659 , pp. 240-249
    • Cameron, A.1    Ewen, M.2    Ross-Degnan, D.3    Ball, D.4    Laing, R.5
  • 17
    • 84971324457 scopus 로고    scopus 로고
    • The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors
    • von der Schulenberg F., Vanderos S., Kanavos P. The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review 2011, 1(18). http://www.healtheconomicsreview.com/content/1/1/18.
    • (2011) Health Economics Review , vol.1 , Issue.18
    • von der Schulenberg, F.1    Vanderos, S.2    Kanavos, P.3
  • 19
    • 0023322117 scopus 로고
    • Price elasticity and adverse selection in the demand for supplementary health insurance
    • Marquis M.S., Phelps C.E. Price elasticity and adverse selection in the demand for supplementary health insurance. Economic Inquiry 1987, 25:299-313.
    • (1987) Economic Inquiry , vol.25 , pp. 299-313
    • Marquis, M.S.1    Phelps, C.E.2
  • 20
    • 84881754373 scopus 로고    scopus 로고
    • Why parallel imports of pharmaceutical products should be forbidden
    • Vicién F. Why parallel imports of pharmaceutical products should be forbidden. European Competition Law Review 1996, 17:219-224.
    • (1996) European Competition Law Review , vol.17 , pp. 219-224
    • Vicién, F.1
  • 21
    • 0642338674 scopus 로고    scopus 로고
    • Differential pricing for pharmaceuticals: reconciling access, R&D and patents
    • Danzon P.M., Towse A. Differential pricing for pharmaceuticals: reconciling access, R&D and patents. International Journal of Health Care Finance Economics 2003, 3(3):183-205.
    • (2003) International Journal of Health Care Finance Economics , vol.3 , Issue.3 , pp. 183-205
    • Danzon, P.M.1    Towse, A.2
  • 22
    • 3042621068 scopus 로고    scopus 로고
    • The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis
    • Pammolli F., Magazzini L., Orsenigo L. The intensity of competition after patent expiry in pharmaceuticals: a cross-country analysis. Revue of Economie Industrielle 2002, 99:107-132.
    • (2002) Revue of Economie Industrielle , vol.99 , pp. 107-132
    • Pammolli, F.1    Magazzini, L.2    Orsenigo, L.3
  • 23
    • 3042677393 scopus 로고    scopus 로고
    • Dynamic competition in pharmaceuticals: on patent expiry, generic penetration and industry structure
    • Magazzini L., Pammolli F., Riccaboni M. Dynamic competition in pharmaceuticals: on patent expiry, generic penetration and industry structure. European Journal of Health Economics 2004, 5:175-182.
    • (2004) European Journal of Health Economics , vol.5 , pp. 175-182
    • Magazzini, L.1    Pammolli, F.2    Riccaboni, M.3
  • 26
    • 47649107602 scopus 로고    scopus 로고
    • Does re-importation reduce price differences for prescription drugs? Lessons from the European Union
    • Kyle M.K., Allsbrook J.S., Schulman K.A. Does re-importation reduce price differences for prescription drugs? Lessons from the European Union. Health Services Research 2008, 43(4):1308-1324.
    • (2008) Health Services Research , vol.43 , Issue.4 , pp. 1308-1324
    • Kyle, M.K.1    Allsbrook, J.S.2    Schulman, K.A.3
  • 27
    • 84887092573 scopus 로고    scopus 로고
    • Cambridge Pharma Consulting, IMS Intelligence
    • Pricing and Market Access Review 2005 2006, Cambridge Pharma Consulting, IMS Intelligence.
    • (2006) Pricing and Market Access Review 2005
  • 28
    • 83055163268 scopus 로고    scopus 로고
    • Pharmaceutical policies in European countries in responds to the global financial crisis
    • Vogler S., Zimmermann N., Leopold C., de Joncheere K. Pharmaceutical policies in European countries in responds to the global financial crisis. Southern Med Review 2011, 4(2):22-32.
    • (2011) Southern Med Review , vol.4 , Issue.2 , pp. 22-32
    • Vogler, S.1    Zimmermann, N.2    Leopold, C.3    de Joncheere, K.4
  • 29
    • 0008348082 scopus 로고    scopus 로고
    • European Medicine Agency, European Medicine Agency
    • European Public Assessment Reports 2012, European Medicine Agency, European Medicine Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp%38mid=WC0b01ac058001d124.
    • (2012) European Public Assessment Reports
  • 30
    • 84887116995 scopus 로고    scopus 로고
    • http://www.whocc.no/atc_ddd_index.
  • 31
    • 84887078610 scopus 로고    scopus 로고
    • Pharma Price Information (PPI) Service, Austrian Health Institute
    • Gesundheit Österreich GmbH 2012, Pharma Price Information (PPI) Service, Austrian Health Institute.
    • (2012) Gesundheit Österreich GmbH
  • 32
    • 84887113470 scopus 로고    scopus 로고
    • General Social Insurance Act § 351c, Federal Law No. 189/1955 (in German)
    • Latest Change by Federal Law I No. 398/2011 2012, General Social Insurance Act § 351c, Federal Law No. 189/1955 (in German).
    • (2012) Latest Change by Federal Law I No. 398/2011
  • 34
    • 84887041037 scopus 로고    scopus 로고
    • European Commission Pharmaceutical Sector Inquiry
    • European Commission Pharmaceutical Sector Inquiry. (2009). http://ec.europa.eu/.
    • (2009)
  • 35
    • 84887116836 scopus 로고    scopus 로고
    • Competition and regulation in the EU regulation of pharmaceuticals
    • Desogus C. Competition and regulation in the EU regulation of pharmaceuticals. European Studies in Law and Economics 2012, 2012.
    • (2012) European Studies in Law and Economics , pp. 2012
    • Desogus, C.1
  • 39
    • 77954490639 scopus 로고    scopus 로고
    • Does pharmaceutical parallel trade serve the objectives of cost control?
    • Kanavos P., Kowal S. Does pharmaceutical parallel trade serve the objectives of cost control?. Eurohealth 2008, 14(8):22-26.
    • (2008) Eurohealth , vol.14 , Issue.8 , pp. 22-26
    • Kanavos, P.1    Kowal, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.